Bhowmick Neil
Transaction: 10/08/2025
BUY
Change
+171,756
Price
Not reported
Filing
12/30/2025
Type
BUY
Kairos Pharma, Ltd.
KAPA • Biotechnology
Strong market move
KAPA+10.18%
vs. previous close $1.67
$1.84
▲ +0.17 (+10.18%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$39.41M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Manageable debt level · 0Healthy liquidity · 27.07Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 14, 2026, 12:39 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$1.84
Change10.18%
Shares Out21.42M
Market Cap$39.41M
Enterprise Value$36.79M
52W Range0.27 - 2.11
Beta1.56
P/E-6.79
P/B9.40
P/FCF-9.93
EV/EBITDA-6.48
EV/FCF-9.27
Price$1.84
Change10.18%
Shares Out21.42M
Market Cap$39.41M
Enterprise Value$36.79M
52W Range0.27 - 2.11
Beta1.56
P/E-6.79
P/B9.40
P/FCF-9.93
EV/EBITDA-6.48
EV/FCF-9.27
Earnings Yield-14.73%
FCF Yield-10.07%
Dividend Yield0.00%
Gross Margin0.00%
Oper. Margin0.00%
Profit Margin0.00%
Debt/Eq0.00
Current Ratio27.07
Quick Ratio27.07
Volume146.27K
Avg Volume1.96M
EPS Surprise-0.01
Investment DNA
How strong this company looks for long-term investors
47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
86/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 27.07Weak profitability
Analyst view
Analyst sentiment and price target
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0
Insider Transactions
Recent executive and insider activity
Bae Hyun W.
Transaction: 10/08/2025
BUY
Change
+19,084
Price
Not reported
Filing
12/23/2025
Type
BUY
Bae Hyun W.
Transaction: 09/16/2025
BUY
Change
+10,000
Price
Not reported
Filing
12/23/2025
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Bhowmick Neil | BUY | +171,756 | Not reported | 10/08/2025 | 12/30/2025 |
| Bae Hyun W. | BUY | +19,084 | Not reported | 10/08/2025 | 12/23/2025 |
| Bae Hyun W. | BUY | +10,000 | Not reported | 09/16/2025 | 12/23/2025 |
| Yu John S | BUY | +190,840 | Not reported | 10/08/2025 | 11/26/2025 |
| Samuelson Doug | BUY | +152,672 | Not reported | 10/08/2025 | 11/26/2025 |
| Singhvi Rahul | BUY | +19,084 | Not reported | 10/08/2025 | 11/26/2025 |
| Keyoung Hansoo Michael | BUY | +19,084 | Not reported | 10/08/2025 | 11/26/2025 |
| Murali Ramachandran | BUY | +152,672 | Not reported | 10/08/2025 | 11/26/2025 |
| Keyoung Hansoo Michael | BUY | +10,000 | Not reported | 09/16/2025 | 11/26/2025 |
| Singhvi Rahul | OTHER | 0 | Not reported | 12/10/2024 | 04/30/2025 |
| Bhowmick Neil | BUY | +14,000 | Not reported | 01/01/2025 | 04/07/2025 |
| Yu John S | BUY | +14,000 | Not reported | 01/01/2025 | 02/24/2025 |
| Murali Ramachandran | BUY | +14,000 | Not reported | 01/01/2025 | 02/24/2025 |
| Murali Ramachandran | BUY | +200 | $1.59 | 11/25/2024 | 11/25/2024 |
| Samuelson Doug | BUY | +2,500 | $1.50 | 11/22/2024 | 11/25/2024 |
| Yu John S | BUY | +4,000 | $1.44 | 11/20/2024 | 11/21/2024 |
| Bae Hyun W. | OTHER | 0 | Not reported | 09/16/2024 | 09/24/2024 |
| Yu John S | OTHER | 0 | Not reported | 09/16/2024 | 09/24/2024 |
| Samuelson Doug | OTHER | 0 | Not reported | 09/16/2024 | 09/24/2024 |
| Keyoung Hansoo Michael | OTHER | 0 | Not reported | 09/16/2024 | 09/24/2024 |